Kalorama Report Describes Challenges for the Clinical Lab Business
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 05/07/12 -- Reimbursement woes have slowed down the market for services in the United States, according to Kalorama Information. The said the market was worth approximately $52.1 billion in 2011, increasing just 1.6% from $51.3 billion in 2010. Several indictors are favorable to the growth of the testing market, but reductions in reimbursement have negatively impacted what labs can earn. This finding was made in Kalorama's most recent report on the subject, "."
The clinical lab services market includes hospital and physician labs billing for tests performed on patients in their care, and lab chains that perform services that hospitals and physicians are outsourcing, most notably LabCorp and Quest Diagnostics. The report indicated that despite several positive trends driving growth in -- the aging and longer-living population and an increase in volumes -- the recent overhaul of the fee schedule has resulted in reductions for almost all tests.
"The overall word in the industry is that this has been a difficult time for billers," said Bruce Carlson, Publisher of Kalorama Information. "The new schedules reduce most fees, which will continue to reduce revenue growth." Kalorama noted that the CPT code for declined from $252 in 2007 to $202 in 2011.
A few positive trends were also noted in the report. Increasing volume was seen last year, and this provided what little revenue growth was achieved, according to Kalorama. A trend toward preventive and risk factor testing has been noted in several disciplines, particularly in the areas of oncology, endocrinology, and gynecology. Physicians in these areas are taking full advantage of testing for early detection and disease prevention. Hospital length of stay's in the United States have been reduced to approximately 4.7 days on average, compared to 5.4 days in 1995 and 4.9 days in 2000. This reduces the physician-patient contact and places a larger role on laboratories to gather, interpret, and deliver information to physicians for the purpose of monitoring a patient's condition and overall health.
The report, "," provides more detail on these trends, breaks out specific testing markets and provides international testing service market data.
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on , and our .
Please direct all media inquiries to:
Bruce Carlson
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.05.2012 - 19:41 Uhr
Sprache: Deutsch
News-ID 143474
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Hospitals, Facilities and Providers
Diese Pressemitteilung wurde bisher 270 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Kalorama Report Describes Challenges for the Clinical Lab Business"
steht unter der journalistisch-redaktionellen Verantwortung von
Kalorama Information (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
